Experience the Quality With Free NAPLEX Exam Questions That Helps Candidates Pass

High-alert medications (e.g., insulin, opioids, anticoagulants, concentrated electrolytes) have a heightened risk of causing significant patient harm if used in error. Evidence-based strategies include standardized concentrations, limited access, auxiliary labels/tall-man lettering, and independent double-checks prior to preparation/administration (particularly for IV chemotherapy, insulin infusions, and heparin). Option B is correct: an independent double-check by a second clinician can intercept dose and product errors. Option A (multiple locations) increases selection errors; centralizing or controlling storage with ADC restrictions is preferred. Option C is incorrect—using tall-man lettering (e.g., hydrOXYzine vs hydrALAZINE) helps distinguish look-alike names; removing it would increase risk. Option D is unsafe; concentrated KCl should not be stocked on patient care units outside controlled areas; premixed solutions should be used to reduce compounding/administration errors.

Calcium and phosphate can precipitate when mixed in PN solutions, risking embolism. Proper order of mixing (phosphate first, calcium last) and careful concentration management prevent precipitation. Amino acids, lipids, and dextrose do not pose this risk.

Glyburide has a long half-life and active metabolites, leading to prolonged hypoglycemia, especially in elderly or renal impairment. Glipizide is shorter-acting with lower hypoglycemia risk. Increasing dose (B) worsens hypoglycemia. Adding insulin (C) is inappropriate. Stopping therapy entirely (D) is unnecessary if switching to a safer sulfonylurea achieves control.

Population health focuses on identifying groups at risk and applying targeted interventions. Screening for A1C >9% identifies uncontrolled diabetics who may need MTM, counseling, and provider follow-up. Reviewing a single patient (A) is micro-level. Counseling at pickup (C) and vancomycin dose adjustment (D) are case-based, not population-focused.

Lithium is renally cleared and reabsorbed with sodium. Thiazide diuretics reduce sodium reabsorption, increasing lithium reabsorption. NSAIDs also decrease lithium clearance. Both cause elevated serum lithium and toxicity. High sodium intake lowers lithium levels, not raises them. Combination of hydrochlorothiazide and ibuprofen is the most likely cause.